As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

CSL Seqirus has announced a strengthened partnership with the UK government that will see the UK become the first country in the world to introduce AUJEMFLU (aTIVc), the companys ...

The SAB brings together leading global experts with complementary expertise across Alzheimer’s disease biology, biomarkers, cognitive assessment, neurophysiology, genetics, data science and ...

Ekterly is now the first and only oral on-demand treatment for HAE to be approved by the UK regulator The Medicines and Healthcare products Regulatory Agency (MHRA) has approved KalVista ...

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...

Kondru joined the Emmes Group in 2024 and most recently served as CEO of Veridix, the company’s AI, technology, and data sciences business. Kondru brings a combination of scientific expertise, global ...

Imfinzi is approved in the US, EU, Japan, China and many other countries around the world as the standard-of-care treatment ...

Join Impetus Digital's pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with idiopathic ...

Novo Nordisk has appointed George Godfrey as Senior Director for Medical and Regulatory in the UK. Godfrey brings over twenty years’ experience at the forefront of healthcare delivery to Novo Nordisk, ...